Empowered Funds, LLC Sarepta Therapeutics, Inc. Transaction History

Empowered Funds, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 05, 2023	SELL	$117.53 - $155.99 $114,944 - $152,558	-978 Reduced 4.21%	22,257 $3.07 Million
Q4 2022 Jan 26, 2023	BUY	$100.86 - $132.13 $2.34 Million - $3.07 Million	23,235 New	23,235 $3.01 Million
Q3 2018 Oct 18, 2018	SELL	$115.31 - $161.51 $1.94 Million - $2.72 Million	-16,835 Closed	0 $0
Q2 2018 Jul 09, 2018	SELL	$71.74 - $153.69 $150,223 - $321,826	-2,094 Reduced 11.06%	16,835 $2.25 Million
Q1 2018 Apr 25, 2018	BUY	$54.02 - $82.27 $1.02 Million - $1.56 Million	18,929 New	18,929 $1.36 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

Stay updated on Empowered Funds, LLC with notifications on news.